Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Updated June 2026 · ClinicalTrials.gov

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Reviewed by TrialFinderData Editorial Team · Updated

6 clinical trials · 6 recruiting · NIH

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has 6 clinical trials registered on ClinicalTrials.gov, with 6 actively recruiting participants. The trials listed below cover 18 conditions across the phases listed in the sidebar. Always discuss any specific trial with your physician before contacting a study site.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)\'s Trial Portfolio

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is a federal-government sponsor. Government-funded trials, including those from the National Institutes of Health, are typically focused on public-health priorities, rare-disease research, and questions where commercial sponsors have less incentive to fund. They are also among the most rigorously documented trials on ClinicalTrials.gov.

6 of Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)'s 6 registered trials are currently recruiting — roughly 100% of the portfolio. A high recruiting share usually points to an active research pipeline with multiple programs at the enrollment stage.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)'s research footprint spans Metabolic Disease (2 trials), panhypopituitarism (1), and gigantism-acromegaly (1) as the top three conditions. The full condition list, sorted by trial count, is in the sidebar.

is the largest single phase in Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)'s portfolio at 100% of registered trials. The full phase breakdown appears in the sidebar.

Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

RECRUITINGNCT00001595

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

There is a variety of tumors affecting the pituitary gland in childhood; some of these tumors (eg craniopharyngioma) are included among the most common central nervous system...

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Enrolling: 20001 location
PanhypopituitarismGigantism/AcromegalyProlactinoma+1
RECRUITINGNCT05600946

Characterization of Dysmorphology in Subjects With Creatine Transporter Deficiency

Background: Creatine transporter deficiency (CTD) is a genetic disorder that mainly affects the brain in males. CTD causes intellectual disability that can be mild to severe....

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Enrolling: 191 location
Cognitive DisorderMetabolic DiseaseAutism Spectrum Disorder
RECRUITINGNCT00250159

Natural History Study of Patients With Excess Androgen

This study will evaluate and gather information in patients with genetic causes of too much androgen (male-like hormone) in order to better understand the effects of too much...

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Enrolling: 30002 locations
Congenital Adrenal Hyperplasia (CAH)Familial Male-Limited Precocious Puberty (FMPP)
RECRUITINGNCT02769975

Evaluation of Children With Endocrine and Metabolic-Related Conditions

Background: Endocrine glands give off hormones. Researchers want to learn more about the disorders that affect these glands in children. These disorders might be caused by...

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Enrolling: 150001 location
Adrenal InsufficiencyGrowth DisorderEndocrine Diseases+2
RECRUITINGNCT05052216

Development of a Wearable Point of Care Monitoring Device for Pediatric Obstructive Sleep Apnea

Background: Obstructive sleep apnea (OSA) occurs when the blockage of the airway causes a person to stop breathing involuntarily for 10 seconds or more throughout the night...

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Enrolling: 1201 location
Pediatric Obstructive Sleep Apnea
RECRUITINGNCT04708431

Androgen Receptor, Implications for Health and Wellbeing: Natural History Study of Individuals With Androgen...

Background: Androgen effects in humans are usually (but not always) mediated by the androgen receptor which is coded for by the androgen receptor gene (AR gene). Androgen...

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Enrolling: 6501 location
Androgen Insensitivity SyndromeMetabolic Parameters in AIS, CAIS, PAIS and MAISTumor Formation in AIS, CAIS, PAIS and MAIS+1

How to Approach a Trial Listing

Each trial card above links to a dedicated page with the official ClinicalTrials.gov data plus a plain-English translation of the eligibility criteria. We translate technical terminology (ECOG performance status, hepatic function values, exclusionary lab thresholds) into language that a patient or caregiver can understand, but the original clinical text and the live ClinicalTrials.gov record always govern any actual eligibility decision.

Before contacting a trial site, write down questions for your treating physician using the framework on our 25 Questions guide. Discuss whether the trial fits your treatment plan, what the time commitment looks like, and whether your insurance will cover the standard-of-care portions. Trials are not a substitute for a treatment plan — they are an addition that needs medical guidance to evaluate.

Authoritative Resources

Verify any trial registration directly on ClinicalTrials.gov. For background on the FDA approval pathway that Phase 3 trials feed into, see the FDA drug approval process. For cancer-specific trial guidance, the National Cancer Institute publishes patient-oriented overviews. For global trial registrations beyond the U.S., the WHO ICTRP aggregates registries from around the world.

Frequently Asked Questions

How many clinical trials does Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) have on ClinicalTrials.gov?

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has 6 clinical trials registered on the federal ClinicalTrials.gov registry, of which 6 are actively recruiting participants right now. These counts come directly from the ClinicalTrials.gov API and are updated as the registry changes.

What conditions does Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) study?

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)'s registered trials cover 18 conditions on ClinicalTrials.gov, led by Metabolic Disease (2 trials), panhypopituitarism (1 trial), gigantism-acromegaly (1 trial), prolactinoma (1 trial), Cushing Disease (1 trial). The complete condition list appears in the sidebar of this page; each condition links to a page listing every recruiting trial in that area, regardless of sponsor.

How do I join a Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) clinical trial?

Joining a clinical trial is a medical decision that should always involve your treating physician. Each trial page on this site includes the eligibility criteria translated into plain English alongside the official clinical text, plus the contact information that the sponsor has registered with ClinicalTrials.gov. Bring the trial information to your doctor before reaching out — they can review the full inclusion and exclusion criteria against your medical history and help you decide whether to pursue screening.

What does the trial phase mean?

Phase 1 trials test safety and dosing in small groups (often 20–80 healthy volunteers or patients). Phase 2 trials evaluate efficacy and side effects in larger groups (100–300 patients with the target condition). Phase 3 trials confirm efficacy and monitor safety in the largest groups (300–3,000+ patients) and form the basis of an FDA approval submission. Phase 4 studies happen after a treatment is approved, monitoring long-term safety and effectiveness in real-world use. Some trials register without a phase — common for device, behavioral, or observational studies.

Where does this trial data come from?

All trial data is pulled directly from the ClinicalTrials.gov API v2, the official federal trial registry maintained by the National Library of Medicine at NIH. Under FDAAA 801, most U.S. drug and device trials are required to register, making ClinicalTrials.gov the most comprehensive source. Sponsors are responsible for keeping their listings current; trial status can shift between data refreshes.

How This Sponsor Page Is Built

Every count on this page is derived directly from ClinicalTrials.gov API v2 records. Trial counts include all trials currently registered to this sponsor; the recruiting count reflects trials with status "Recruiting" or equivalent. Plain-English eligibility translations on each linked trial page preserve the original clinical text alongside an accessible version. Read the full methodology for the data pipeline and limitations.

Source: ClinicalTrials.gov API v2, maintained by the National Library of Medicine at NIH. Public domain. Cite as: "TrialFinderData. Data: ClinicalTrials.gov."

Medical disclaimer: This page is informational, not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Last updated 2026-06-26 · 6 trials tracked for Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).